Sponsors

Sponsors

 

Platinum Sponsor

 

Boehringer Ingelheim
Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for. Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies and to this day remains family-owned. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. In 2016, Boehringer Ingelheim achieved net sales of around 15.9 billion euros. With more than three billion euros, R&D expenditure corresponds to 19.6 per cent of net sales.

Social responsibility comes naturally to Boehringer Ingelheim. That is why the company is involved in social projects such as the “Making More Health” initiative. Boehringer Ingelheim also actively promotes workforce diversity and benefits from its employees’ different experiences and skills. Furthermore, the focus is on environmental protection and sustainability in everything the company does.

More information about Boehringer Ingelheim can be found on www.boehringer-ingelheim.com or in our annual report: http://annualreport.boehringer-ingelheim.com.

 

Roche
Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience.

 

 

Silver Sponsor

 

Bayer
Bayer

 

 

 

Sponsors

 

 

                       

 

                                   

 

 

 

Supporters

 

 

 

About the Foundation for Sarcoidosis Research

The Foundation for Sarcoidosis Research is the nation’s leading nonprofit organization dedicated to finding a cure for this disease and to improving care for sarcoidosis patients. Since its establishment in 2000, FSR has fostered over $4 million in sarcoidosis-specific research efforts and has worked diligently to provide resources to thousands.


FSR provides funding and collaborations for research and initiatives which focus on the understanding of sarcoidosis, addresses the causes of the disease, counters the suffering of patients, and advances the potential for a cure. Through collaborations and partnerships, FSR is producing game-changing initiatives toward a cure.

, www.stopsarcoidosis.org

Important Dates

Congress Dates: June 07th - 9th 2018 

Abstract Submission launch: July 2017 

Registration & Hotel launch: July 2017 

Deadline for abstract submission: April 1st 2018 

Deadline for early registration fee: March 9th 2018 

Deadline for middle registration fee: April 30th 2018 

Organized by

AFEA S.A. TRAVEL AND CONGRESS SERVICES

+30 210 36 68 842
+30 210 36 43 511
info@wasog2018.com

Follow us on